Subscribe to Newsletter

Hongming Chen

author hongming chen

Hongming Chen is the Chief Scientific Officer at Kala Pharmaceuticals, Inc. Kala is the licensee of the MPP technology and is developing the technology for applications in various mucosal organs including the eye

Content by Hongming Chen:

 Business & Profession Retina

The Nano State

| Robert Langer, Justin Hanes, Hongming Chen

Imagine prescribing eye drops to treat wet AMD, or delivering genes to the retina of patients with retinitis pigmentosa. Nanotechnology can do both – and it could potentially transform ophthalmology
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

July Issue of The Ophthalmologist
Disclaimer element

This new disclaimer element is now part of all brands. It is editable on the start page and will be shown on all pages

Once confirmed we store a cookie to not show the disclaimer again.